Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,163 | -40,859 | -16,013 | -11,552 | -7,366 |
| Depreciation Amortization | 240 | 1,054 | 621 | 323 | 243 |
| Accounts receivable | -151 | -77 | -37 | 34 | 138 |
| Other Working Capital | 377 | -2,687 | -2,894 | -3,091 | -559 |
| Other Operating Activity | 4,725 | 25,576 | 4,333 | 3,616 | 2,959 |
| Operating Cash Flow | $-3,972 | $-16,993 | $-13,990 | $-10,670 | $-4,585 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -485 | -521 | -507 | -26 |
| Net Acquisitions | N/A | 30,163 | 30,163 | 30,163 | 30,163 |
| Purchase Sale Intangibles | N/A | N/A | 50 | N/A | N/A |
| Other Investing Activity | -30 | -59 | 50 | -13 | 0 |
| Investing Cash Flow | $-60 | $29,619 | $29,692 | $29,643 | $30,137 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,514 | 5,022 | 5,022 | 5,022 |
| Debt Repayment | -34 | -119 | -82 | -82 | -82 |
| Common Stock Issued | -97 | 41 | 4 | 4 | 4 |
| Other Financing Activity | -5 | 1,754 | 1,765 | 1,776 | 1,786 |
| Financing Cash Flow | $-136 | $7,190 | $6,709 | $6,720 | $6,730 |
| Beginning Cash Position | 20,608 | 792 | 792 | 792 | 792 |
| End Cash Position | 16,440 | 20,608 | 23,203 | 26,485 | 33,074 |
| Net Cash Flow | $-4,168 | $19,816 | $22,411 | $25,693 | $32,282 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,972 | -16,993 | -13,990 | -10,670 | -4,585 |
| Capital Expenditure | N/A | -535 | -521 | -507 | -26 |
| Free Cash Flow | -3,972 | -17,528 | -14,511 | -11,177 | -4,611 |